We found that the application of cholesterol depletion through MβCD in mice not only restricts cancer cell survival and aggressiveness relative to cholesterol levels but also engages the STING agonist-driven anti-tumor response as well as checkpoint blockage. The gene discussed is STING1; the disease is cancer.